Cargando…
Is it appropriate for acute respiratory distress syndrome patients with neuromuscular blocking agents?
Autores principales: | Tan, Zhimin, He, Qiyu, Shi, Xiaoting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868350/ https://www.ncbi.nlm.nih.gov/pubmed/36737340 http://dx.doi.org/10.1016/j.asjsur.2023.01.074 |
Ejemplares similares
-
Neuromuscular blocking agents for acute respiratory distress syndrome
por: Torbic, Heather, et al.
Publicado: (2019) -
Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?
por: Torbic, Heather, et al.
Publicado: (2019) -
Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study
por: Courcelle, Romain, et al.
Publicado: (2020) -
Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents
por: Higashi, Michiko, et al.
Publicado: (2019) -
Role of Neuromuscular Blocking Agents in Acute Respiratory Distress Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials
por: Wei, Xue-biao, et al.
Publicado: (2020)